We are live on
!
Find out more
DM
Deerfield Management Portfolio holdings
AUM
$8.48B
1-Year Est. Return
99.04%
This Fund
S&P 500
This Quarter
Est. Return
+6.55%
1 Year Est. Return
+99.04%
3 Year Est. Return
+273.78%
5 Year Est. Return
+280.99%
10 Year Est. Return
+2,168.14%
AUM
$8.48B
AUM Growth
+$646M
(+8.3%)
Cap. Flow
-$773M
Cap. Flow
% of AUM
-9.12%
Top 10 Holdings %
Top 10 Hldgs %
50.85%
Holding
160
New
9
Increased
15
Reduced
10
Closed
78
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Inspire Medical Systems
INSP
|
+$83.8M |
| 2 |
Syndax Pharmaceuticals
SNDX
|
+$82.1M |
| 3 |
Pfizer
PFE
|
+$80.9M |
| 4 |
Genmab
GMAB
|
+$73.8M |
| 5 |
Dianthus Therapeutics
DNTH
|
+$59.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Neurocrine Biosciences
NBIX
|
+$76.2M |
| 2 |
Revolution Medicines
RVMD
|
+$60.3M |
| 3 |
Phreesia
PHR
|
+$33.8M |
| 4 |
Ventas
VTR
|
+$27.4M |
| 5 |
Spyre Therapeutics
SYRE
|
+$23.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 84.65% |
| 2 | Consumer Discretionary | 0% |
| 3 | Consumer Staples | 0% |
| 4 | Financials | 0% |
| 5 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Abbott
ABT
$175B
| – | – |
-11,449
| Closed | -$1.43M |
|
77
Addus HomeCare
ADUS
$2.14B
| – | – |
-15,871
| Closed | -$1.7M |
|
78
Align Technology
ALGN
$12.7B
| – | – |
-11,000
| Closed | -$1.72M |
|
79
Alignment Healthcare
ALHC
$4.26B
| – | – |
-164,345
| Closed | -$3.25M |
|
80
Amphastar Pharmaceuticals
AMPH
$871M
| – | – |
-14,852
| Closed | -$398K |
|
81
Arvinas
ARVN
$517M
| – | – |
-68,057
| Closed | -$807K |
|
82
Alphatec Holdings
ATEC
$1.31B
| – | – |
-57,277
| Closed | -$1.21M |
|
83
AtriCure
ATRC
$1.77B
| – | – |
-52,076
| Closed | -$2.06M |
|
84
Avanos Medical
AVNS
$1.17B
| – | – |
-167,061
| Closed | -$1.88M |
|
85
Azenta
AZTA
$1.21B
| – | – |
-25,835
| Closed | -$859K |
|
|
BFLY.WS
86
DELISTED
Butterfly Network Inc Warrants
BFLY.WS
| – | – |
-733,333
| Closed | -$12.9K |
|
87
BioLife Solutions
BLFS
$1.42B
| – | – |
-120,211
| Closed | -$2.91M |
|
88
BellRing Brands
BRBR
$1.41B
| – | – |
-11,996
| Closed | -$321K |
|
89
Boston Scientific
BSX
$65.4B
| – | – |
-24,941
| Closed | -$2.38M |
|
90
Cardinal Health
CAH
$53.5B
| – | – |
-8,985
| Closed | -$1.85M |
|
91
CalciMedica
CALC
$11.6M
| – | – |
-1,300,000
| Closed | -$8.57M |
|
92
Chemed
CHE
$6.77B
| – | – |
-6,215
| Closed | -$2.66M |
|
93
Cigna
CI
$74.5B
| – | – |
-9,203
| Closed | -$2.53M |
|
94
CONMED
CNMD
$1.3B
| – | – |
-52,555
| Closed | -$2.13M |
|
95
Cooper Companies
COO
$14B
| – | – |
-7,786
| Closed | -$638K |
|
96
CorMedix
CRMD
$661M
| – | – |
-1,107,944
| Closed | -$12.9M |
|
97
CorVel
CRVL
$3.15B
| – | – |
-27,629
| Closed | -$1.87M |
|
98
Quest Diagnostics
DGX
$23.3B
| – | – |
-18,392
| Closed | -$3.19M |
|
99
Doximity
DOCS
$3.87B
| – | – |
-51,942
| Closed | -$2.3M |
|
100
DaVita
DVA
$15.2B
| – | – |
-20,909
| Closed | -$2.38M |
|
Similar funds
FT
GRQ
AV
PCM
VA
QC
IC
NW
Deerfield Management's Q1 2026 Portfolio in Review
As of Q1 2026, Deerfield Management held 160 positions worth $8.48B, up 8.3% from $7.83B the previous quarter. Its ten largest holdings account for 51% of the portfolio.
Deerfield Management withdrew a net $773M in Q1 2026, closing 78 positions and reducing 10 holdings. Its most notable exit was Phreesia, an estimated $33.8M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 85% of assets, down from 87% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.
Against the trend, Deerfield Management opened a new position in Syndax Pharmaceuticals worth $88.3M.
- Deerfield Management's largest Q1 2026 buy was Syndax Pharmaceuticals: 3,779,900 shares worth $88.3M.
- Deerfield Management added most to Inspire Medical Systems in Q1 2026, an estimated $83.8M increase.
- Deerfield Management's biggest Q1 2026 reduction was Neurocrine Biosciences, cutting an estimated $76.2M.
- Deerfield Management fully exited Phreesia in Q1 2026, selling an estimated $33.8M.
- Deerfield Management's ten largest holdings make up 51% of its $8.48B portfolio in Q1 2026.
- Deerfield Management opened 9 new positions and closed 78 in Q1 2026.
- Deerfield Management's portfolio value rose 8.3% quarter-over-quarter to $8.48B.
Based on Deerfield Management's 13F filing for Q1 2026, filed 15 May 2026.